Acadia Healthcare Company, Inc. $ACHC Shares Bought by Maverick Capital Ltd.

Maverick Capital Ltd. raised its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 45.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,314,116 shares of the company’s stock after buying an additional 408,697 shares during the period. Maverick Capital Ltd.’s holdings in Acadia Healthcare were worth $30,737,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of ACHC. Clough Capital Partners L P acquired a new position in Acadia Healthcare during the first quarter worth $5,359,000. Aberdeen Group plc increased its position in Acadia Healthcare by 72.3% during the fourth quarter. Aberdeen Group plc now owns 743,925 shares of the company’s stock worth $10,556,000 after buying an additional 312,172 shares in the last quarter. Louisiana State Employees Retirement System acquired a new position in shares of Acadia Healthcare in the first quarter worth $957,000. SG Americas Securities LLC lifted its position in shares of Acadia Healthcare by 717.8% in the fourth quarter. SG Americas Securities LLC now owns 292,425 shares of the company’s stock valued at $4,150,000 after acquiring an additional 256,669 shares in the last quarter. Finally, Prescott Group Capital Management L.L.C. acquired a new position in Acadia Healthcare in the 4th quarter valued at about $2,838,000.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ACHC. UBS Group boosted their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. TD Cowen upped their target price on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Guggenheim increased their target price on Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Finally, Barclays lifted their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $28.69.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $32.50 on Tuesday. The business’s fifty day moving average price is $27.78 and its 200 day moving average price is $23.36. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $2.99 billion, a P/E ratio of -2.66, a PEG ratio of 11.51 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.28 by $0.09. The company had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The firm’s revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.